Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop. Researchers now explore the challenges and outline approaches to improved vaccines.
Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop. Researchers now explore the challenges and outline approaches to improved vaccines.